| Today's News and Trends | New technology now being considered by the FDA for approval can capture coronary inflammation on CCTA images and provide risk assessments. What could this mean for the future of cardiac care? We spoke to one researcher to learn more. New technology now being considered by the FDA for approval can capture coronary inflammation on CCTA images and provide risk assessments. What could this mean for the future of cardiac care? We spoke to one researcher to learn more. | | |
| Kestra Medical Technologies, known for its wearable heart monitors and defibrillators, intends to sell 10 million common shares priced somewhere between $14 and $16 per share. Kestra Medical Technologies, known for its wearable heart monitors and defibrillators, intends to sell 10 million common shares priced somewhere between $14 and $16 per share. | | |
| Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. | | |
| The paclitaxel-coated device, already approved in Europe and other parts of the world, will be tested on more than 1,200 patients for a new international trial. If the study is a success, Medtronic hopes to gain regulatory approval in the United States and Japan. The paclitaxel-coated device, already approved in Europe and other parts of the world, will be tested on more than 1,200 patients for a new international trial. If the study is a success, Medtronic hopes to gain regulatory approval in the United States and Japan. | | |
| | How safe is it to perform cardiac surgery on a pregnant patient? When should care teams try to deliver the baby first and then complete the procedure? A team of Mayo Clinic researchers addressed those very questions, and many others, in a new analysis. How safe is it to perform cardiac surgery on a pregnant patient? When should care teams try to deliver the baby first and then complete the procedure? A team of Mayo Clinic researchers addressed those very questions, and many others, in a new analysis. | | |
| Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke. Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke. | | |
| The company's AI-powered CCTA assessments have already been used to help manage more than 400,000 heart patients around the world. The company's AI-powered CCTA assessments have already been used to help manage more than 400,000 heart patients around the world. | | |
| Transfemoral TAVR is not always a viable option. In those instances, the two most effective alternatives are transcarotid access and transcaval access, according to a new SCAI expert consensus statement. Transfemoral TAVR is not always a viable option. In those instances, the two most effective alternatives are transcarotid access and transcaval access, according to a new SCAI expert consensus statement. | | |
| | IHF cardiologists can come from a variety of backgrounds, but they all share the same goal: to ensure complex heart failure patients receive the best care possible. IHF cardiologists can come from a variety of backgrounds, but they all share the same goal: to ensure complex heart failure patients receive the best care possible. | | |
| American College of Cardiology President Cathie Biga, MSN, says Medicare payment reform remains a top priority going forward. Site-neutral payments and improved access to PAD screening are two other issues close to the ACC's heart. American College of Cardiology President Cathie Biga, MSN, says Medicare payment reform remains a top priority going forward. Site-neutral payments and improved access to PAD screening are two other issues close to the ACC's heart. | | |
| The FDA has already shown great interest in the drug, which is designed to help AFib patients reduce their stroke and systemic embolism risks. The FDA has already shown great interest in the drug, which is designed to help AFib patients reduce their stroke and systemic embolism risks. | | |
| | Less alarm fatigue in overworked pediatric nurses means more time for imperiled pediatric patients. Less alarm fatigue in overworked pediatric nurses means more time for imperiled pediatric patients. | | |
| “When healthcare prices are hidden, large corporate entities like hospitals and insurance companies benefit," the White House said. “When healthcare prices are hidden, large corporate entities like hospitals and insurance companies benefit," the White House said. | | |
| |
|
| ![]() | |
|
